Trending News
-
Company
Braemar Hotels & Resorts Explores Strategic Sale—Here’s What You Need To Know
Braemar Hotels explores a potential sale to unlock private market value, leveraging its luxury portfolio…
Read More » -
-
-
-
-
-
-
-
Tech
-
Company
CrowdStrike Sees AI as Both Threat and Opportunity in Cybersecurity Market
CrowdStrike (NASDAQ: CRWD), a leading cybersecurity firm, is positioning itself at the forefront of the industry as artificial intelligence reshapes…
Read More » -
Company
QuantumScape Surges 20% as Solid-State Battery Demo Ignites Investor Optimism
Shares of QuantumScape (QS) surged a massive 20% on Monday, hitting approximately $9.50, grabbing investor attention after a volatile summer…
Read More » -
Company
C3.ai Faces Rocky Start Under New CEO Amid Falling Revenue
C3.ai (AI) shares took a steep dip this Wednesday following the release of its disappointing first-quarter results, signaling investor skepticism…
Read More »
Biotech
-
Biotech
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
Eli Lilly has taken a commanding position in the obesity drug market with its GLP-1 agonist Zepbound, and now the…
Read More » -
Biotech
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
BioNTech’s recent $1.25 billion all-stock acquisition of former rival CureVac marks a definitive shift in strategy—away from COVID-19 vaccine reliance…
Read More » -
Biotech
Bristol Myers’ $11.1 Billion Bet on BioNTech: Is Oncology The New Growth Engine?
Bristol Myers has inked a transformative partnership for BNT327, a bispecific PD-L1/VEGF-A antibody developed by BioNTech, with a $1.5 billion…
Read More »
Healthcare
-
Company
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Phreesia is charting new territory with its recently announced $160 million all-cash acquisition of AccessOne Parent Holdings, a healthcare financing…
Read More » -
Company
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share,…
Read More » -
Company
Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?
Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion…
Read More »
-
Cannabis
Grove Inc (GRVI): Untouchable Leader Within the CBD-Based Industry?
Cannabidiol, commonly known as CBD, is a naturally occurring chemical compound found in cannabis plants…
Read More » -
-
-
Follow us on Twitter